Bridging Innovative RNA Biology and Drug Discovery
Our mission:
By combining multidisciplinary academic innovators with biotech-inspired objectives and focus, our goal is to uncover novel disease solutions by advancing the science of RNA regulation, developing new technological platforms, and discovering early-stage therapeutics.
Our Approach:
Recruit and nucleate current and next generation leaders in RNA biology and cultivate environment of collaboration, technology innovation and entrepreneurship
Build multi-disciplinary drug discovery teams focused on translating transformative RNA discoveries into therapeutics utilizing biotech best practices
Integrate academic innovators with therapeutic teams to bridge the gap between discovery and clinically applicable therapies
CENTER Happenings
recent media & publications
Dr. Steven Boeynams received the NIH Director's New Innovator Award to study how neuropathology mimics infectious disease and how the innate immune system responds. Congrats!
Congratulations to Dr. Trey Westbrook and Dr. Jitendra Meena on their recent publication “MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer” in Cancer Discovery!
Dr. Furqan Fazal was awarded an R35 Maximizing Investigators’ Research Award (MIRA) from the National Institute of General Medical Sciences (NIGMS) to study RNA localization. Congrats!
Drs. Steven Boeynams and Furqan Fazal received grant funding from the Welch Foundation to further our understanding of the chemistry of RNA. Congratulations!
upcoming events
Dr. Sofia Quinodoz from Princeton University will be presenting our next seminar on Wednesday December 4th, in M112 at 3:00 P.M. We hope you can join us!
Join us for our next RNA Group presentations November 25th at 10am in M112. Matthew Seasock from the Rodriguez Lab and Rares Drula from the Calin Lab will present their work. See you there